202797-03-3 Usage
Uses
Used in Pharmaceutical Industry:
3-Amino-N-Boc-9-azabicyclo[3.3.1]nonane is used as a synthetic intermediate for the development of various pharmaceuticals and bioactive compounds. Its unique bicyclic amine structure and the N-Boc protecting group allow for selective reactions, facilitating the synthesis of complex molecules with potential therapeutic applications.
Used in Medicinal Chemistry Research:
3-Amino-N-Boc-9-azabicyclo[3.3.1]nonane is utilized as a key building block in medicinal chemistry research. Its unique structure and the ability to protect the amine functionality make it a valuable tool for the design and synthesis of novel compounds with potential therapeutic properties. Researchers can explore its reactivity and functional group manipulation to create new drug candidates for various diseases and conditions.
Used in Organic Synthesis:
3-Amino-N-Boc-9-azabicyclo[3.3.1]nonane is employed as a versatile building block in organic synthesis. The N-Boc protecting group allows for selective reactions at other sites in the molecule, making it an attractive starting material for the preparation of a wide range of organic compounds. Its unique bicyclic amine structure can be further modified and functionalized to access diverse chemical entities with potential applications in various industries, including pharmaceuticals, agrochemicals, and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 202797-03-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,2,7,9 and 7 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 202797-03:
(8*2)+(7*0)+(6*2)+(5*7)+(4*9)+(3*7)+(2*0)+(1*3)=123
123 % 10 = 3
So 202797-03-3 is a valid CAS Registry Number.
InChI:InChI=1/C13H24N2O2/c1-13(2,3)17-12(16)15-10-5-4-6-11(15)8-9(14)7-10/h9-11H,4-8,14H2,1-3H3
202797-03-3Relevant academic research and scientific papers
SUBSTITUTED PIPERIDINE COMPOUNDS
-
, (2016/06/01)
The present disclosure provides substituted piperidine compounds having Formula (I), and the pharmaceutically acceptable salts and solvates thereof, wherein R1, B, X, and Z are defined as set forth in the specification. The present disclosure i
